Stocks
Acusphere, Inc.ACUS
PNKHealthcareBiotechnology$0.00
Price as of · delayed, not real-time
A specialty pharmaceutical company focused on developing and commercializing cardiovascular therapies, with its lead product candidate designed for ultrasound imaging applications. The company has faced significant financial challenges, including bankruptcy proceedings, which investors track due to its high-risk profile and potential for regulatory milestones.
52W Range: $0.00-$0.00
Congressional Interest in Acusphere, Inc. (ACUS)
1 member of Congress has disclosed 1 trade in Acusphere, Inc. (ACUS), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading ACUS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-05-24 | MICHAEL T. MCCAUL | sell | $1K-$15K |